Amyloid β-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)

Molecular Brain Research

Volumn 106, Issue 1-2, 2002, Pages 94-100

  Kubo, Takekazu ^a   Nishimura, Satoko ^a   Oda, Tomiichiro ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Alzheimer's disease; Amyloid peptide; Early endosome; EEA1; Exocytosis; Phosphatidylinositol 3 OH kinase; Phosphorylation; Rab5

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN; AUTOANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAB PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG ACTIVITY; ENDOSOME; ENZYME PHOSPHORYLATION; HELA CELL; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANTIBODIES; BIOLOGICAL MARKERS; CHROMONES; COLORING AGENTS; ENDOSOMES; ENZYME INHIBITORS; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RAB5 GTP-BINDING PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; VESICULAR TRANSPORT PROTEINS;

EID: 0037109201     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00416-3     Document Type: Article

References (27)

1. Abe K., Saito H. Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci. Res. 31:1998;295-305.
2. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-103.
3. Isobe I., Michikawa M., Yanagisawa K. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid β-protein and chloroquine in cultured rat astrocytes. Neurosci. Lett. 266:1999;129-132.
4. Isobe I., Yanagisawa K., Michikawa M. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) causes Akt phosphorylation and morphological changes in intracellular organellae in cultured rat astrocytes. J. Neurochem. 77:2001;274-280.
5. Itoh A., Nitta A., Nadai M., Nishimura K., Hirose M., Hasegawa T., Nabeshima T. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem. 66:1996;1113-1117.
6. Ivins K.J., Bui E.T., Cotman C.W. β-Amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol. Dis. 5:1998;365-378.
7. Jones A.T., Clague M.J. Phosphatidylinositol 3-kinase activity is required for early endosome fusion. Biochem. J. 311:1995;31-34.
8. Kaneko I., Yamada N., Sakuraba Y., Kamenosono M., Tutumi S. Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J. Neurochem. 65:1995;2585-2593.
9. 26] β-amyloid 1-40 to toxic and proteinase-resistant fragments. Neuroscience. 104:2001;1003-1011.
10. Li G., D'Souza-Schorey C., Barbieri M.A., Roberts R.L., Klippel A., Williams L.T., Stahl P.D. Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5. Proc. Natl. Acad. Sci. USA. 92:1995;10207-10211.
11. Liu Y., Schubert D. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J. Neurochem. 69:1997;2285-2293.
12. Liu Y., Peterson D.A., Schubert D. Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl. Acad. Sci. USA. 95:1998;13266-13271.
13. Martin D., Salinas M., Lopez-Valdaliso R., Serrano E., Recuero M., Cuadrado A. Effect of the Alzheimer amyloid fragment Aβ(25-35) on Akt/PKB kinase and survival of PC12 cells. J. Neurochem. 78:2001;1000-1008.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
15. Oda T., Pasinetti G.M., Osterburg H.H., Anderson C., Johnson S.A., Finch C.E. Purification and characterization of brain clusterin. Biochem. Biophys. Res. Commun. 204:1994;1131-1136.
16. Patel A.J., Gunasekera S., Jen A., Rohan de Silva H.A. β-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration. Neuroreport. 7:1996;2026-2030.
17. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein (Review). Ann. NY Acad. Sci. 924:2000;17-25.
18. Shearman M.S., Hawtin S.R., Tailor V.J. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J. Neurochem. 65:1995;218-227.
19. Shearman M.S., Ragan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
20. Simonsen A., Lippe R., Christoforidis S., Gaullier J.M., Brech A., Callaghan J., Toh B.H., Murphy C., Zerial M., Stenmark H. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 394:1998;494-498.
21. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., Imahori K. Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β Neurosci. Lett. 203:1996;33-36.
22. Toker A., Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase (Review). Nature. 387:1997;673-676.
23. Tomidokoro Y., Harigaya Y., Matsubara E., Ikeda M., Kawarabayashi T., Okamoto K., Shoji M. Impaired neurotransmitter systems by Aβ amyloidosis in APPsw transgenic mice overexpressing amyloid β protein precursor. Neurosci. Lett. 292:2000;155-158.
24. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
25. Wei W., Wang X., Kusiak J.W. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277:2002;17649-17656.
26. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
27. Zhang L., Xing G.Q., Barker J.L., Chang Y., Maric D., Ma W., Li B.S., Rubinow D.R. α-Lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway. Neurosci. Lett. 312:2001;125-128.